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ABSTRACT
Survival rates for babies born extremely prematurely increased between 1995 and 2006, but few improvements in
neonatal morbidity occurred despite appropriate interventions. The current study was undertaken to examine the
neurologic and developmental outcomes for babies born at less than 27 weeks’ gestation in 2006 and to compare the
survival and outcomes at 3 years of age with those of babies born at 22 to 25 weeks’ gestation in 1995.
Data were collected for all babies born at 22 to 26 weeks’ gestation during 2006. Families were contacted for assessment
when the children were aged 30 to 36 months. In 1995, data were collected for babies born at 22 to 25 weeks’ gestation.
Cerebral palsy was identified by neurologic examination and classified as severe, moderate, and mild, or no impairment in
motor, developmental, sensory, and communication domains. Data from these 1995 and 2006 cohorts were combined to
allow comparisons after reclassification of 2006 outcomes using the 1995 definitions.
A total of 576 children, aged 27 to 48 months, were evaluated in person. Information was available from local data records
for another 191 children, aged 18 to 50 months, of whom 68 (38%) had neurodevelopmental impairment. Of babies born at
less than 27 weeks’ gestation in 2006, 77 (13.4%) had severe, and 68 (11.8%) had moderate impairment. Rates for cognitive,
communication, and motor impairment were 16%, 11%, and 8%, respectively. An inverse relationship was observed
between gestational age and prevalence of moderate or severe impairment, that is, 45% of survivors at 22 to 23 weeks to 30%
at 24 weeks, 25% at 25 weeks, and 20% at 26 weeks. Eighty-three children had cerebral palsy, 32 (39%) with diplegia,
21 (25%) with hemiplegia, 10 (12%) with quadriplegia, and 20 (24%) with other types. Nine children (11%) with
cerebral palsy had severe sensory impairment; developmental testing showed severe, moderate, or mild impairment in
47 (57%), 30 (46%), and 6 (7%) children, respectively. For births at less than 27 weeks’ gestation in 2006, survival free
of moderate or severe impairment ranged from 8% at 23 weeks’ gestation to 59% at 26 weeks’ gestation. Based on
babies who received active intervention after birth, rates ranged from 11% at 23 weeks’ gestation to 60% at 26 weeks’
gestation and for babies receiving intensive care from 15% to 61%, respectively.
When comparing to the historical cohort, survival to age 3 years for babies admitted to intensive care was 39% in 1995
and 52% in 2006. Overall, the proportion of babies admitted to intensive care who survived with severe disability increased
by 2.6%, but a higher proportion survived without disability (11%). Survival without disability increased significantly at 25
and 24 weeks’ gestation (15% and 10%, respectively), but changes were not statistically significant at 23 and 22 weeks’
gestation (2.5% and j0.4%). In 1995, 43 children (18%) had severe disabilities, and 54 (23%) had other disabilities
compared with 60 (19%) and 54 (16%), respectively, in 2006. Developmental scores of 55 or less were present in 92% in
1995 and 89% in 2006. Mean scores for these children increased from 84 in 1995 to 91 in 2006.
The apparent improvement in survival and disability-free survival is encouraging but tempered by a lack of reduction in
the prevalence of severe disability. The results show evidence of improvement in the proportion of babies who survive
without disability, an improvement in developmental scores, and a reduction in neurologic morbidity, but no change in
rates of severe impairment.
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EDITORIAL COMMENT
(Historically, the advent of neonatal intensive care
units (NICUs) has dramatically lowered the rate of
neonatal mortality at low gestational ages. Around
the world, in countries without the resources to
have NICUs, babies born before 28 weeks’ ges-
tation have essentially a 100% rate of mortality.
Although we have been able to push the threshold
of viability down to 24 and even 23 or 22 weeks of
gestation, the long-term morbidity of these neo-
nates has continued to be quite severe and in a
large proportion. There continue to be improve-
ments made in NICU care with less aggressive
use of high levels of oxygen or ventilation. Thus,
the current article from the BMJ, abstracted
above, examined the long-term outcomes at 3
years of age in neonates born at 22 to 25 weeks’
gestation in 1995 and 2006.
This study found that survival rates between
the 2 time periods were improved from 39% to
52% with a great dependence on the specific
gestational age (ranging from 7% at 22 weeks up
to 66% at 25 weeks). Discouragingly, there was no
difference in the rate of severe morbidity in survi-
vors. However, there was an increase in neonates
who survived without disability from 23% to 34%.
Again, there was a strong relationship between
gestational age and the prevalence of moderate or
severe impairment (45% of survivors at 22/23
weeks to 25% at 25 weeks). However, much of this
difference appeared due to improved survival rates
as the rate of survival without severe disability was
nonsignificantly increased from 59% to 65%.
Although these data come from the United
Kingdom, I think they are incredibly useful for
counseling our patients here in the United States
where long-term data are hard to come by. Given
that about half of the survivors at 22 and 23 weeks’
gestation have moderate or severe morbidity,
which includes cerebral palsy, blindness, deaf-
ness, or cognitive delay, how should patients be
counseled? Furthermore, how much autonomy
over decisions regarding resuscitation should
patients have at various gestational ages? In my
conversations with colleagues around the country,
nearly all would not even offer/allow resuscitation
before 22 weeks. Alternatively, at 26 weeks and
beyond, it is often not a parent choice because the
neonatal outcomes are deemed to be so good.
Between these gestations, I believe a range of
practices exist from institutions where resuscita-
tion before 24 weeks is not offered but done
begrudgingly if parents inquire, to routine resus-
citation of all 23 weeks’ gestation neonates.
At my institution, patients undergo informed
consent and choose resuscitation versus comfort
care at 22 through 25 weeks’ gestation. It is rare
that we resuscitate a 22-week neonate and very
rare that we don’t at 25 weeks, but patients are
given the opportunity to choose. Seemingly, this
is better care than an absolute rule because it
allows patients to incorporate their beliefs and
preferences regarding this decision. Unfortu-
nately, these patients often have only a short time
to make the decision, and it is unclear how well they
understand the severity of the long-term outcomes
and even how to utilize the varying probabilities to
make the decision. It is a very different decision
than one about whether to undergo pregnancy
termination when diagnosed with a Down syn-
drome fetus. In that case, patients know for certain
that their fetus has Down syndrome, and although
there is a range of outcomes, the range is rela-
tively narrow compared with the outcomes at 22
to 25 weeks’ gestation. Although the average
outcome might be similar, the severe outcomes
from 22- to 25-week neonates may be viewed as
much worse than Down syndrome, and the sur-
vivors without disability have better outcomes
than those with Down syndrome. So, not only do
patients have to think about preferences toward
the outcomes, but also they have to understand
and use the probabilities related to the range of
outcomes. I think this is an incredibly complex
decision, one for which few expectant parents are
prepared. Other than providing detailed informa-
tion and responding to questions, we have little to
help them make this monumental decision that
can have enormous consequences. Furthermore,
in this setting, it is not uncommon for these parents
to interact with several different providers, most
notably an obstetrician or MFM and a neonatolo-
gist. In my practice, I make every effort to do this
counseling together to ensure a single message
regarding this complicated information.VABC)
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